Pharmaceutical Business Review
Regulatory Affairs
Anonymous User | Login

SOCMA Renews Call For Permanent Security Standards

Published: 03-Mar-2010

The Society of Chemical Manufacturers and Affiliates (SOCMA), in testimony to a key Senate panel, has again urged Congress to make the current risk-based chemical facility security standards permanent, or at least reauthorize the program until 2015.

Stephen Poorman, international EHS&S manager of Fujifilm Imaging Colorants, in remarks to a hearing before the Senate Committee on Homeland Security and Governmental Affairs, encouraged lawmakers to preserve the progress made under the current regulatory program.

Mr Poorman argued that Congress can assure the continued success of the existing program by passing S. 2996, the Continuing Chemical Facilities Antiterrorism Security Act, introduced by Senator Susan Collins (R-ME), together with Senators Mark Pryor (D-AR), George Voinovich (R-OH), and Mary Landrieu (D-LA).

Specifically, the bill’s requirement of mandatory implementation of so-called inherently safer technology (IST) would shift DHS’s focus from securing our industry against terrorism to conducting engineering and chemistry assessments, while potentially phasing out legitimate products. He noted that, in contrast to the bipartisan Senate bill, the House version passed without a single minority vote and in spite of expert testimony advising against mandatory IST.

He said: “It is a wonder why IST proponents still support such a provision when there is so much uncertainty about the concept and how DHS could apply it – and during a historic economic recession in which our nation’s unemployment rate still stands at nearly 10%.

“Spending money to comply with new regulations necessarily causes companies to assess how they will pay for it. There isn’t much available capital these days for manufacturers to take on new regulations aimed at their very livelihood, especially small manufacturers.”

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Carpmaels & Ransford

Patent and Trade Mark Attorneys ...

GxPi

Consulting and Compliant Document Management Solutions ...

Cutting Edge Information

Pharmaceutical Business Intelligence Reports ...

Pharmaceutical Development Services

Pharmaceutical, Regulatory and Medical Device Consultancy ...

Luzzatto & Luzzatto

Patent Attorneys ...

Innovaro

Partnering, Licensing and Business Development for the Life Science and Biopharmaceutical Industries...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Your IP at Risk in Collaborations!

Free white paper: Ten steps to protect your R&D investment within partnerships. ...

Why, When and How to Conduct 14C Human Studies

Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...

Why CAPA Still Matters

This free white paper explores the needs and effectiveness of correct CAPA control, how to ...

What is ZeoCool?

ZeoCool is a revolutionary step in the design of temperature controlled packaging. Control ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

ValiChrom - Validation and Scale Down Modelling Columns

The first purpose designed LC columns for reliable validation results. For more informatio ...

Related Companies

No items to display

Suppliers Product News

GxPi Launches Hosted eDMS for Small to Medium Life Science Companies

Regulatory compliance experts GxPi announce the availability of its leading Electronic Document Management System (eDMS) x-docs™ as a hosted software service.

GxPi’s x-docs™ Electronic Document Management Solution Achieves Regulatory Compliance for FDAS

GxPi, a leading provider of consulting services and compliance-based products to the pharmaceutical, biopharmaceutical and healthcare industries, has announced that hosted x-docs™, the company's hosted electronic document management solution (eDMS) solution, has been successfully implemented by Food and Drug Analytical Services Ltd. (FDAS) to manage routine quality control (QC) records for their customers.

Renovo Selects GxPi’s x-docs™ CAPA Module as a Hosted System to Manage Vital Documents for the Drug Development Process

Renovo is a biopharmaceutical product company and a leader in the discovery and development of drugs to reduce scarring, improve wound healing and enhance tissue regeneration. The company has around 100 employees based at its state-of-the-art facility in Manchester, UK. It consists of research facilities, a quality control (QC) laboratory operating to good manufacturing practice (GMP) and a clinical trials unit supported by nurses and surgeons.

Transatlantic Pharmaceutical Experts PDS Expand Team to Cover API Supplier Auditing

Pharmaceutical Development Services Ltd (PDS), is expanding its team of associates to meet growing demand and to provide the Active Pharmaceutical Ingredient (API) auditing capability demanded by companies keen to maintain their quality credentials with regulatory authorities.

Top Pharmaceutical Expert Joins PDS Front Line Team

Pharmaceutical Development Services Ltd (PDS) has announced a major addition to its front line consultancy team with the appointment of Graham Clapperton to head up PDS quality services.

Medical Device Experts Join PDS to Extend Consultancy Range

Pharmaceutical Development Services (PDS) have announced a major extension to their range of consultancy services with the appointment of two new associates, both of whom are experts in the rapidly growing area of medical devices.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address